Eric Venker Roivant Sciences Ltd. (ROIV) insider trading activity

Eric Venker is President & Immunovant CEO of Roivant Sciences Ltd.. Currently has a direct ownership of 1.46 Million shares of ROIV, which is worth approximately $16.8 Million. The most recent transaction as insider was on Jun 09, 2023, when has been sold 299,384 shares (Common Shares) at a price of $3.85 per share, resulting in proceeds of $1,152,628. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.46M

30.98% 3M change

227.63% 12M change

Total Value Held $16.8 Million

Eric Venker Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 09 2023	BUY Exercise of conversion of derivative security	$1,152,628 $3.85 p/Share	299,384 Added 23.78%	959,481 Common Shares
Jun 07 2023	SELL Open market or private sale	$1,979 $9.85 p/Share	201 Reduced 0.03%	660,097 Common Shares
Jun 07 2023	BUY Exercise of conversion of derivative security	$773 $3.85 p/Share	201 Added 0.03%	660,298 Common Shares
May 23 2023	SELL Other acquisition or disposition	$150,128 $9.58 p/Share	15,671 Reduced 2.32%	660,097 Common Shares
May 23 2023	SELL Open market or private sale	$4,087 $9.85 p/Share	415 Reduced 0.06%	675,768 Common Shares
May 23 2023	BUY Exercise of conversion of derivative security	$1,597 $3.85 p/Share	415 Added 0.06%	676,183 Common Shares
May 09 2023	SELL Open market or private sale	$2,203,422 $9.23 p/Share	238,724 Reduced 26.1%	675,768 Common Shares
May 09 2023	BUY Exercise of conversion of derivative security	$919,087 $3.85 p/Share	238,724 Added 20.7%	914,492 Common Shares
May 08 2023	SELL Open market or private sale	$546,569 $8.93 p/Share	61,206 Reduced 8.31%	675,768 Common Shares
May 08 2023	BUY Exercise of conversion of derivative security	$235,643 $3.85 p/Share	61,206 Added 7.67%	736,974 Common Shares
May 04 2023	SELL Open market or private sale	$737,355 $8.3 p/Share	88,838 Reduced 11.62%	675,768 Common Shares
May 04 2023	BUY Exercise of conversion of derivative security	$342,026 $3.85 p/Share	88,838 Added 10.41%	764,606 Common Shares
May 03 2023	SELL Open market or private sale	$997,584 $8.4 p/Share	118,760 Reduced 14.95%	675,768 Common Shares
May 03 2023	BUY Exercise of conversion of derivative security	$457,226 $3.85 p/Share	118,760 Added 13.0%	794,528 Common Shares
May 02 2023	SELL Open market or private sale	$904,223 $8.29 p/Share	109,074 Reduced 13.9%	675,768 Common Shares
May 02 2023	BUY Exercise of conversion of derivative security	$419,934 $3.85 p/Share	109,074 Added 12.2%	784,842 Common Shares
May 01 2023	SELL Open market or private sale	$525,321 $8.59 p/Share	61,155 Reduced 8.3%	675,768 Common Shares
May 01 2023	BUY Exercise of conversion of derivative security	$235,446 $3.85 p/Share	61,155 Added 7.66%	736,923 Common Shares
Apr 28 2023	SELL Open market or private sale	$642,220 $8.47 p/Share	75,823 Reduced 10.09%	675,768 Common Shares
Apr 28 2023	BUY Exercise of conversion of derivative security	$291,918 $3.85 p/Share	75,823 Added 9.16%	751,591 Common Shares
Apr 27 2023	SELL Open market or private sale	$625,604 $8.51 p/Share	73,514 Reduced 9.81%	675,768 Common Shares
Apr 27 2023	BUY Exercise of conversion of derivative security	$283,028 $3.85 p/Share	73,514 Added 8.93%	749,282 Common Shares
Apr 26 2023	SELL Open market or private sale	$631,365 $8.66 p/Share	72,906 Reduced 9.74%	675,768 Common Shares
Apr 26 2023	BUY Exercise of conversion of derivative security	$280,688 $3.85 p/Share	72,906 Added 8.87%	748,674 Common Shares
Apr 20 2023	SELL Payment of exercise price or tax liability	$127,221 $8.8 p/Share	14,457 Reduced 2.09%	675,768 Common Shares

Eric Venker

President & Immunovant CEO

London, X0

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ROIV shares.

Notify only if

Value

Insider Trading

Get notified when an Roivant Sciences Ltd. insider buys or sells ROIV shares.

Notify only if

Operation

Value

Type

News

Receive news related to Roivant Sciences Ltd.

Track Activities on ROIV

Account